Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Titles
NEW
 Top 50 Non-Healthcare Titles
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Hidradenitis Suppurativa Global Market Report 2025
Request Sample Buy Now
Global Hidradenitis Suppurativa Market Report 2025

Report Price : $4490.00

Pages : 200

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Hidradenitis Suppurativa Global Market Report 2025

By Skin Condition (Folliculitis, Pimples, Boils, Deep-Acne), By Product (Tablet, Intravenous (IV) Injection), By Route Of Administration (Oral, Parenteral), By Treatment (Medications, Surgery, Photodynamic Therapy (PDT), Laser Treatment, Other Treatments), By End User (Hospital, Specialty Clinic, Homecare, Other End Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Hidradenitis Suppurativa Market Overview

• Hidradenitis Suppurativa market size has reached to $1.16 billion in 2024

• Expected to grow to $1.63 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%

• Growth Driver: The Rise In The Prevalence Of Skin Diseases

• Market Trend: Transforming Hidradenitis Suppurativa Treatment Through Innovative Therapies

• North America was the largest region in 2024.

What Is Covered Under Hidradenitis Suppurativa Market?

Hidradenitis suppurativa (HS) is a chronic skin condition that causes painful lumps deep in the skin, usually on parts of the body where skin touches the skin, such as the armpits, inner thighs, and groin area. These lumps frequently appear where skin contacts skin, such as the armpits, inner thighs, and groin.

The main types of skin conditions in hidradenitis suppurativa are folliculitis, pimples, boils, and deep acne. Folliculitis refers to a common skin condition that occurs when hair follicles become inflamed or infected, and various types of treatments are used for folliculitis, such as creams, pills, and laser hair removal treatments. The product types included are tablets and intravenous (IV) injections, which are administered through oral and parenteral routes in treatments such as medications, surgery, photodynamic therapy (PDT), laser treatment, and others. The end users are hospitals, specialty clinics, homecare, and others.

Hidradenitis Suppurativa Market Size and growth rate 2025 to 2029: Graph

What Is The Hidradenitis Suppurativa Market Size 2025 And Growth Rate?

The hidradenitis suppurativa market size has grown strongly in recent years. It will grow from $1.16 billion in 2024 to $1.24 billion in 2025 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to increased diagnosis awareness, limited treatment options, advancements in dermatology, rising disease prevalence, patient advocacy initiatives

What Is The Hidradenitis Suppurativa Market Growth Forecast?

The hidradenitis suppurativa market size is expected to see strong growth in the next few years. It will grow to $1.63 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to biologic therapies development, precision medicine approaches, clinical trial expansion, global initiatives and funding, healthcare policy support. Major trends in the forecast period include advanced immunomodulatory therapies, telemedicine and remote monitoring, patient-centric care, minimally invasive surgical interventions, personalized lifestyle recommendations.

The forecast of 6.9% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose a significant challenge for the U.S. by restricting access to biologic therapies and advanced wound care products imported from Germany and Denmark, potentially worsening disease progression and increasing dermatology expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Hidradenitis Suppurativa Market Segmented?

1) By Skin Condition: Folliculitis, Pimples, Boils, Deep-Acne

2) By Product: Tablet, Intravenous (IV) Injection

3) By Route Of Administration: Oral, Parenteral

4) By Treatment: Medications, Surgery, Photodynamic Therapy (PDT), Laser Treatment, Other Treatments

5) By End User: Hospital, Specialty Clinic, Homecare, Other End Users

Subsegments:

1) By Folliculitis: Acute Folliculitis, Chronic Folliculitis

2) By Pimples: Non-Inflammatory Pimples, Inflammatory Pimples

3) By Boils: Single Boil, Recurrent Boils

4) By Deep-Acne: Cysts, Nodules

What Is Driving The Hidradenitis Suppurativa Market? The Rise In The Prevalence Of Skin Diseases

The rise in the prevalence of skin diseases is driving the growth of the hidradenitis suppurativa market going forward. Skin diseases refer to a wide range of skin problems, including those attributed to bacterial infections, viral infections, fungal infections, allergy symptoms, skin malignancies, and parasites. Hidradenitis suppurativa (HS), a chronic and severe skin disorder, is driving the development of new products and services for its management due to increased awareness, accurate diagnosis, a growing patient pool, and research advancements. For instance, in January 2024, according to the American Cancer Society, a US-based non-profit organization dedicated to eliminating cancer, there will be 108,270 reported cases of skin cancer, reflecting a 3.2% increase from the 104,930 cases reported in 2023. Therefore, the rise in the prevalence of skin diseases propels the growth of the hidradenitis suppurativa industry.

What Is Driving The Hidradenitis Suppurativa Market? Increasing Healthcare Expenditure

Increasing healthcare expenditure is driving the growth of the hidradenitis suppurativa market going forward. Healthcare expenditure refers to an expense that covers all costs associated with providing health services, family planning, nutrition, and emergency help with a focus on health. Increasing healthcare expenditure also allows for the creation of comprehensive patient support programs, ensuring better management of hidradenitis suppurativa and an overall positive impact on the quality of care and research in the field. For instance, in March 2022, according to the 2021–2030 National Health Expenditure (NHE) report published by the Centers for Medicare & Medicaid Services, a US-based Department of Health and Human Services department, the annual increase in national health spending was predicted to average 5.1% between 2021 and 2030, reaching approximately $6.8 trillion by 2030. Therefore, increasing healthcare expenditure propels the growth of the hidradenitis suppurativa industry.

Who Are The Major Players In The Global Hidradenitis Suppurativa Market?

Major companies operating in the hidradenitis suppurativa market include Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Eli Lilly and Co Ltd., UCB S.A., Leo Pharma A/S, Almirall S.A., Acelyrin Inc., AnaptysBio Inc., Arcutis Biotherapeutics Inc., Otsuka Pharmaceutical Co. Ltd., Yamo Pharmaceuticals, Bayer AG, AstraZeneca plc, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Chemocentryx, Priovant Therapeutics, Aristea Therapeutics, Samsung Bioepis, Organon, Union Therapeutics, Revance Therapeutics, Dermavant Sciences, Dermira Inc., MedImmune LLC, Taro Pharmaceutical Industries Ltd., Immunic Inc.

What Are The Key Trends Of The Global Hidradenitis Suppurativa Market? Transforming Hidradenitis Suppurativa Treatment Through Innovative Therapies

Utilization of biologics is a key trend gaining popularity in the hidradenitis suppurativa market. Major companies operating in the hidradenitis suppurativa market are investing in research and development, resulting in an approved biologic therapy for hidradenitis suppurativa and sustaining their position in the market. For instance, in June 2023, the European regulatory authority approved Novartis AG, a Switzerland-based pharmaceutical company, for Cosentyx for hidradenitis suppurativa. Cosentyx is the first and only completely human biologic that specifically blocks interleukin-17A, an essential cytokine associated with hidradenitis suppurative disease. Cosentyx is a well-established medication that has been clinically researched for over 14 years.

What Are The Key Trends Of The Global Hidradenitis Suppurativa Market? Novartis Partners With Emirates Dermatology Society To Advance Hidradenitis Suppurativa Awareness

Strategic partnerships are the key trend gaining popularity in hidradenitis suppurativa market. Major companies operating in hidradenitis suppurativa market are focused on forming strategic alliances to strengthen their position in the market. For instance, in June 2023, Novartis, a Switzerland based pharma company entered a partnership with a UAE based in the continuous improvement in the quality of dermatology services Emirates Dermatology Society (EDS), to take on Hidradenitis Suppurativa awareness in the UAE. The collaboration will also deliver insights to help healthcare providers and policymakers support patients affected by the debilitating disease. Novartis and EDS will establish scientific, educational platforms targeting dermatologists and patients in the UAE. Both organizations will capture and generate local data on hidradenitis suppurativa through Real World Evidence (RWE).

Need data on a specific region in this market?
Request Customisation

Hidradenitis Suppurativa Market Merger And Acquisition: Amgen Acquires Chemocentryx Elevating Treatment Portfolio

In October 2022, Amgen Inc., a US-based biopharmaceutical company, acquired ChemoCentryx Inc. for $3.7 billion. Through this acquisition, Amgen Inc. enhances its market position by adding TAVNEOS from ChemoCentryx to its product portfolio. TAVNEOS, an FDA-approved gastrointestinal-restricted complement 5a receptor inhibitor, is a potential complementary therapy for individuals with hidradenitis suppurativa. ChemoCentryx, Inc., is a US-based biopharmaceutical company specializing in medications for autoimmune and oncology diseases such as hidradenitis suppurativa.

Regional Outlook For The Global Hidradenitis Suppurativa Market

North America was the largest region in the hidradenitis suppurativa market in 2024. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

What Defines the Hidradenitis Suppurativa Market?

The hidradenitis suppurativa (HS) market consists of revenues earned by entities providing treatment to axillary-mammary-inguinal hidradenitis suppurativa, follicular hidradenitis suppurativa, gluteal hidradenitis suppurativa, and syndromic hidradenitis suppurativa. The market value includes the value of related goods sold by the service provider or included within the service offering. The hidradenitis suppurativa (HS) market also includes sales of surgery biologics, antibiotics, immunosuppressive drugs, zinc supplements, and retinoids. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Hidradenitis Suppurativa Industry?

The hidradenitis suppurativa market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the hidradenitis suppurativa industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Hidradenitis Suppurativa Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $1.24 billion
Revenue Forecast In 2034 $1.63 billion
Growth Rate CAGR of 6.9% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Skin Condition: Folliculitis, Pimples, Boils, Deep-Acne
2) By Product: Tablet, Intravenous (IV) Injection
3) By Route Of Administration: Oral, Parenteral
4) By Treatment: Medications, Surgery, Photodynamic Therapy (PDT), Laser Treatment, Other Treatments
5) By End User: Hospital, Specialty Clinic, Homecare, Other End Users Subsegments: 1) By Folliculitis: Acute Folliculitis, Chronic Folliculitis
2) By Pimples: Non-Inflammatory Pimples, Inflammatory Pimples
3) By Boils: Single Boil, Recurrent Boils
4) By Deep-Acne: Cysts, Nodules
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Eli Lilly and Co Ltd., UCB S.A., Leo Pharma A/S, Almirall S.A., Acelyrin Inc., AnaptysBio Inc., Arcutis Biotherapeutics Inc., Otsuka Pharmaceutical Co. Ltd., Yamo Pharmaceuticals, Bayer AG, AstraZeneca plc, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Chemocentryx, Priovant Therapeutics, Aristea Therapeutics, Samsung Bioepis, Organon, Union Therapeutics, Revance Therapeutics, Dermavant Sciences, Dermira Inc., MedImmune LLC, Taro Pharmaceutical Industries Ltd., Immunic Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Hidradenitis Suppurativa Market Characteristics

3. Hidradenitis Suppurativa Market Trends And Strategies

4. Hidradenitis Suppurativa Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Hidradenitis Suppurativa Growth Analysis And Strategic Analysis Framework

5.1. Global Hidradenitis Suppurativa PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Hidradenitis Suppurativa Market Growth Rate Analysis

5.4. Global Hidradenitis Suppurativa Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Hidradenitis Suppurativa Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Hidradenitis Suppurativa Total Addressable Market (TAM)

6. Hidradenitis Suppurativa Market Segmentation

6.1. Global Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Folliculitis

Pimples

Boils

Deep-Acne

6.2. Global Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tablet

Intravenous (IV) Injection

6.3. Global Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Parenteral

6.4. Global Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Medications

Surgery

Photodynamic Therapy (PDT)

Laser Treatment

Other Treatments

6.5. Global Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital

Specialty Clinic

Homecare

Other End Users

6.6. Global Hidradenitis Suppurativa Market, Sub-Segmentation Of Folliculitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Acute Folliculitis

Chronic Folliculitis

6.7. Global Hidradenitis Suppurativa Market, Sub-Segmentation Of Pimples, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Non-Inflammatory Pimples

Inflammatory Pimples

6.8. Global Hidradenitis Suppurativa Market, Sub-Segmentation Of Boils, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Single Boil

Recurrent Boils

6.9. Global Hidradenitis Suppurativa Market, Sub-Segmentation Of Deep-Acne, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cysts

Nodules

7. Hidradenitis Suppurativa Market Regional And Country Analysis

7.1. Global Hidradenitis Suppurativa Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Hidradenitis Suppurativa Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hidradenitis Suppurativa Market

8.1. Asia-Pacific Hidradenitis Suppurativa Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hidradenitis Suppurativa Market

9.1. China Hidradenitis Suppurativa Market Overview

9.2. China Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hidradenitis Suppurativa Market

10.1. India Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hidradenitis Suppurativa Market

11.1. Japan Hidradenitis Suppurativa Market Overview

11.2. Japan Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hidradenitis Suppurativa Market

12.1. Australia Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hidradenitis Suppurativa Market

13.1. Indonesia Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hidradenitis Suppurativa Market

14.1. South Korea Hidradenitis Suppurativa Market Overview

14.2. South Korea Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hidradenitis Suppurativa Market

15.1. Western Europe Hidradenitis Suppurativa Market Overview

15.2. Western Europe Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hidradenitis Suppurativa Market

16.1. UK Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hidradenitis Suppurativa Market

17.1. Germany Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hidradenitis Suppurativa Market

18.1. France Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hidradenitis Suppurativa Market

19.1. Italy Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hidradenitis Suppurativa Market

20.1. Spain Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hidradenitis Suppurativa Market

21.1. Eastern Europe Hidradenitis Suppurativa Market Overview

21.2. Eastern Europe Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hidradenitis Suppurativa Market

22.1. Russia Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hidradenitis Suppurativa Market

23.1. North America Hidradenitis Suppurativa Market Overview

23.2. North America Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hidradenitis Suppurativa Market

24.1. USA Hidradenitis Suppurativa Market Overview

24.2. USA Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hidradenitis Suppurativa Market

25.1. Canada Hidradenitis Suppurativa Market Overview

25.2. Canada Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hidradenitis Suppurativa Market

26.1. South America Hidradenitis Suppurativa Market Overview

26.2. South America Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hidradenitis Suppurativa Market

27.1. Brazil Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hidradenitis Suppurativa Market

28.1. Middle East Hidradenitis Suppurativa Market Overview

28.2. Middle East Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hidradenitis Suppurativa Market

29.1. Africa Hidradenitis Suppurativa Market Overview

29.2. Africa Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hidradenitis Suppurativa Market Competitive Landscape And Company Profiles

30.1. Hidradenitis Suppurativa Market Competitive Landscape

30.2. Hidradenitis Suppurativa Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Eli Lilly and Co Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Hidradenitis Suppurativa Market Other Major And Innovative Companies

31.1. UCB S.A.

31.2. Leo Pharma A/S

31.3. Almirall S.A.

31.4. Acelyrin Inc.

31.5. AnaptysBio Inc.

31.6. Arcutis Biotherapeutics Inc.

31.7. Otsuka Pharmaceutical Co. Ltd.

31.8. Yamo Pharmaceuticals

31.9. Bayer AG

31.10. AstraZeneca plc

31.11. Sun Pharmaceutical Industries Ltd.

31.12. Aurobindo Pharma

31.13. Chemocentryx

31.14. Priovant Therapeutics

31.15. Aristea Therapeutics

32. Global Hidradenitis Suppurativa Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hidradenitis Suppurativa Market

34. Recent Developments In The Hidradenitis Suppurativa Market

35. Hidradenitis Suppurativa Market High Potential Countries, Segments and Strategies

35.1 Hidradenitis Suppurativa Market In 2029 - Countries Offering Most New Opportunities

35.2 Hidradenitis Suppurativa Market In 2029 - Segments Offering Most New Opportunities

35.3 Hidradenitis Suppurativa Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Hidradenitis Suppurativa Market, Sub-Segmentation Of Folliculitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Hidradenitis Suppurativa Market, Sub-Segmentation Of Pimples, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Hidradenitis Suppurativa Market, Sub-Segmentation Of Boils, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Hidradenitis Suppurativa Market, Sub-Segmentation Of Deep-Acne, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Hidradenitis Suppurativa Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Hidradenitis Suppurativa Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Pfizer Inc. Financial Performance
  • Table 81: Johnson & Johnson Financial Performance
  • Table 82: AbbVie Inc. Financial Performance
  • Table 83: Novartis AG Financial Performance
  • Table 84: Eli Lilly and Co Ltd. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Hidradenitis Suppurativa Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Hidradenitis Suppurativa Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Hidradenitis Suppurativa Market, Sub-Segmentation Of Folliculitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Hidradenitis Suppurativa Market, Sub-Segmentation Of Pimples, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Hidradenitis Suppurativa Market, Sub-Segmentation Of Boils, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Hidradenitis Suppurativa Market, Sub-Segmentation Of Deep-Acne, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Hidradenitis Suppurativa Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Hidradenitis Suppurativa Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Hidradenitis Suppurativa Market, Segmentation By Skin Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Hidradenitis Suppurativa Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Hidradenitis Suppurativa Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Pfizer Inc. Financial Performance
  • Figure 81: Johnson & Johnson Financial Performance
  • Figure 82: AbbVie Inc. Financial Performance
  • Figure 83: Novartis AG Financial Performance
  • Figure 84: Eli Lilly and Co Ltd. Financial Performance

Next-Gen Healthcare Services : Market Forecast, Transformation, and Long-Term Trajectories

Read More About Next-Gen Healthcare Services : Market Forecast, Transformation, and Long-Term Trajectories

Hospitals And Outpatient Care Centers Growth Trajectory: Key Forecasts and Strategic Insights

Read More About Hospitals And Outpatient Care Centers Growth Trajectory: Key Forecasts and Strategic Insights

ICU Beds Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Read More About ICU Beds Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Emerging Trends Redefining the ICU Beds Market Landscape: Innovative Products In Influenza Diagnostic Market Development

Read More About Emerging Trends Redefining the ICU Beds Market Landscape: Innovative Products In Influenza Diagnostic Market Development

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Read More About A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Fertility Services Market 2023 – By Procedure (Assisted Reproductive Technology (Art), In-Vitro Fertilization, Artificial Insemination), By Service (Fresh Non-Donor, Frozen Non-Donor, Egg And Embryo Banking, Fresh Donor,...

View Report

Value Based Care Payment Market 2023 – By Model (Accountable Care Organization (ACO), Bundled Payments, Patient-Centered Medical Home (PCMH), Pay For Performance (P4P)), By Deployment Type (Cloud Based, On-Premise), By E...

View Report

Crushed Stone Mining Global Market Report 2020 - By Type (Limestone Mining, Granite Mining)...

View Report

Dimension Stone Mining Global Market Report 2020 - By Type (Marble, Granite, Limestone, Sandstone)...

View Report

Stone Mining And Quarrying Global Market Report 2020 - By Type (Dimension Stone Mining, Crushed Stone Mining), By Organization Size (large Enterprises, Small And Medium Enterprises), COVID-19 Impact...

View Report

Truck Transportation Global Market Report 2020 - By Type (General Freight Trucking, Specialized Freight Trucking Local General Freight Trucking, Long-Distance General Freight Trucking, Automobiles And Heavy Equipment, Bu...

View Report

Telehealth Market 2021 - By Type (Software, Services, Hardware), By Mode Of Delivery (Cloud-Based, On-Premise), By Application (Teleradiology, Telepsychiatry, Telepathology, Teledermatology, Telecardiology), By End-User ...

View Report

Telemedicine Services Global Market Report 2025 – By Type (Web-based, Cloud-based, On-premises), By Technology outlook (Real-Time Telemedicine Services, Store-And-Forward Telemedicine Services), By Application (Teleradio...

View Report

Frequently Asked Questions

Hidradenitis suppurativa (HS) is a chronic skin condition that causes painful lumps deep in the skin, usually on parts of the body where skin touches the skin, such as the armpits, inner thighs, and groin area. These lumps frequently appear where skin contacts skin, such as the armpits, inner thighs, and groin. For further insights on this market, request a sample here

The market major growth driver - The Rise In The Prevalence Of Skin Diseases. For further insights on this market, request a sample here

The hidradenitis suppurativa market size has grown strongly in recent years. It will grow from $1.16 billion in 2024 to $1.24 billion in 2025 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to increased diagnosis awareness, limited treatment options, advancements in dermatology, rising disease prevalence, patient advocacy initiatives. The hidradenitis suppurativa market size is expected to see strong growth in the next few years. It will grow to " $1.63 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to biologic therapies development, precision medicine approaches, clinical trial expansion, global initiatives and funding, healthcare policy support. Major trends in the forecast period include advanced immunomodulatory therapies, telemedicine and remote monitoring, patient-centric care, minimally invasive surgical interventions, personalized lifestyle recommendations. For further insights on this market, request a sample here

The hidradenitis suppurativamarket covered in this report is segmented –
1) By Skin Condition: Folliculitis; Pimples; Boils; Deep-Acne
2) By Product: Tablet; Intravenous (IV) Injection
3) By Route Of Administration: Oral; Parenteral
4) By Treatment: Medications; Surgery; Photodynamic Therapy (PDT); Laser Treatment; Other Treatments
5) By End User: Hospital; Specialty Clinic; Homecare; Other End Users Subsegments:
1) By Folliculitis: Acute Folliculitis; Chronic Folliculitis
2) By Pimples: Non-Inflammatory Pimples; Inflammatory Pimples
3) By Boils: Single Boil; Recurrent Boils
4) By Deep-Acne: Cysts; Nodules For further insights on this market, request a sample here

North America was the largest region in the hidradenitis suppurativa market in 2024. The regions covered in the hidradenitis suppurativa market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on this market, request a sample here.

Major companies operating in the hidradenitis suppurativa market include Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Eli Lilly and Co Ltd., UCB S.A., Leo Pharma A/S, Almirall S.A., Acelyrin Inc., AnaptysBio Inc., Arcutis Biotherapeutics Inc., Otsuka Pharmaceutical Co. Ltd., Yamo Pharmaceuticals, Bayer AG, AstraZeneca plc, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Chemocentryx, Priovant Therapeutics, Aristea Therapeutics, Samsung Bioepis, Organon, Union Therapeutics, Revance Therapeutics, Dermavant Sciences, Dermira Inc., MedImmune LLC, Taro Pharmaceutical Industries Ltd., Immunic Inc. . For further insights on this market, request a sample here.

Major trends in this market include Transforming Hidradenitis Suppurativa Treatment Through Innovative Therapies. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Hidradenitis Suppurativa Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top